United Therapeutics Corporation Property, Plant and Equipment, Gross
United Therapeutics Corporation (UTHR) had Property, Plant and Equipment, Gross of $2.54 billion as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-05
- 2026-06-30: Property, Plant and Equipment, Gross $2.54B.
- 2026-03-31: Property, Plant and Equipment, Gross $2.43B.
- 2025-12-31: Property, Plant and Equipment, Gross $2.30B.
- 2025-09-30: Property, Plant and Equipment, Gross $2.10B.
| Period end | Property, Plant and Equipment, Gross | Property, Plant and Equipment, Gross as first filed |
|---|---|---|
| 2026-06-30 | $2.54B 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $2.43B 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $2.30B 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $2.10B 10-Q · filed 2025-10-29 | |
| 2025-06-30 | $1.89B 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $1.81B 10-Q · filed 2025-04-30 | |
| 2024-12-31 | $1.71B 10-K · filed 2026-02-25 | |
| 2024-09-30 | $1.63B 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $1.56B 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $1.52B 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $1.47B 10-K · filed 2025-02-26 | |
| 2023-09-30 | $1.41B 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $1.35B 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $1.29B 10-Q · filed 2023-05-03 | |
| 2022-12-31 | $1.24B 10-K · filed 2024-02-21 | |
| 2022-09-30 | $1.22B 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $1.16B 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $1.14B 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $1.12B 10-K · filed 2023-02-22 | |
| 2021-09-30 | $1.07B 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $1.04B 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $1.03B 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $1.04B 10-K · filed 2022-02-24 | |
| 2019-12-31 | $1.01B 10-K · filed 2021-02-24 | |
| 2018-12-31 | $934.30M 10-K · filed 2020-02-26 | |
| 2017-12-31 | $748.20M 10-K · filed 2019-02-27 | |
| 2016-12-31 | $664.30M 10-K · filed 2018-02-21 | |
| 2015-12-31 | $650.70M 10-K · filed 2017-02-22 | $650.66M 10-K · filed 2016-02-25 |
| 2014-12-31 | $613.39M 10-K · filed 2016-02-25 | |
| 2013-12-31 | $571.16M 10-K · filed 2015-02-24 | |
| 2012-12-31 | $531.68M 10-K · filed 2014-02-25 | |
| 2011-12-31 | $419.32M 10-K · filed 2013-02-26 | |
| 2010-12-31 | $344.24M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |